Quality Assurance

Good Laboratory Practices (GLP) compliant: validated by AFSSAPS:

• 01/2002 (status "B")
• 12/2003 (status "A")
• 12/2005 (status "A")
• 12/2007 (status "A")

S7A: Guideline on safety pharmacology studies for human pharmaceuticals
Step 5, July 2001

S7B: Guideline on Safety Pharmacology studies for assessing the potential for delayed ventricular repolarisation (QT interval prolongation) by human pharmaceuticals
Step 4, May 2005
Seen as an extension of S7A